Skip to content
Inciteful Med

Women's Health & Pregnancy with Factor XIII Deficiency

Last updated:

Factor XIII deficiency poses risks like recurrent miscarriage and heavy menstrual bleeding, but successful pregnancy is achievable with proper management. Treatment typically involves prophylactic Factor XIII replacement to secure placental attachment and prevent postpartum hemorrhage.

Key Takeaways

  • • Untreated Factor XIII deficiency carries a high risk of recurrent miscarriage due to weak placental attachment.
  • • Heavy menstrual bleeding is common and can be managed with hormones, antifibrinolytics, or factor replacement.
  • • Factor XIII infusion frequency often increases to every two weeks during the third trimester as blood volume rises.
  • • Delivery requires Factor XIII activity levels of at least 30-50% to prevent postpartum hemorrhage.

For women with Factor XIII (FXIII) deficiency, reproductive health requires careful coordination with a hematology team. While the condition poses challenges, modern treatment strategies allow for successful, full-term pregnancies and safe management of heavy cycles [1][2].

Managing Heavy Periods (Menorrhagia)

Many women with FXIII deficiency experience menorrhagia—heavy or prolonged menstrual bleeding [3][4]. This can lead to iron deficiency and fatigue. Even in mild cases, the risk of heavy periods is significantly higher than in the general population [5].

Management often includes:

  • Hormonal Control: Birth control can be very effective in reducing menstrual flow [6].
  • Antifibrinolytics: Medications like tranexamic acid help the body hold onto clots longer [7].
  • Factor Replacement: Some women may need extra Factor XIII infusions during their period [8].

Factor XIII and Pregnancy

One of the most significant risks for women with untreated FXIII deficiency is a very high rate of recurrent miscarriage [2][9]. Factor XIII is essential for the placenta to attach firmly to the lining of the uterus [10][11][1]. Without enough Factor XIII, the “glue” holding the placenta in place is too weak, leading to pregnancy loss [12][1].

Managing the Third Trimester

As a pregnancy progresses, the body goes through major changes that affect how medicine works:

  • Increased Blood Volume: A pregnant woman’s blood volume increases significantly, which can “dilute” the Factor XIII in her system [2].
  • Shortened Half-Life: The body’s metabolism often speeds up, meaning the Factor XIII is cleared out faster than usual [12].
  • Adjusting the Schedule: Because of these changes, many women need to increase their infusion frequency—often moving from monthly to every 2 weeks—during the third trimester to keep their levels above the safe threshold of 10-20% [12][2].

Delivery and Postpartum Safety

The time of delivery is the period of highest risk for postpartum hemorrhage (severe bleeding after birth) [5][3]. To ensure a safe delivery, doctors aim to have FXIII activity levels at 30-50% or higher [1][13].

Both plasma-derived and recombinant Factor XIII (rFXIII) have been used safely and effectively during pregnancy to achieve healthy births [14][12][2]. Because FXIII deficiency causes delayed bleeding, medical teams must remain vigilant for hemorrhage that can occur days or even weeks after birth [15][3]. Delivery should always take place in a hospital where hematologists and obstetricians can work together [1][16].

Frequently Asked Questions

Can I have a safe pregnancy with Factor XIII deficiency?
Yes, women with Factor XIII deficiency can have successful, full-term pregnancies with careful management. Treatment involving factor replacement therapy is essential to help the placenta attach firmly to the uterine wall and prevent miscarriage.
Why does Factor XIII deficiency cause miscarriage?
Untreated Factor XIII deficiency carries a very high risk of recurrent miscarriage because the protein is necessary for the placenta to anchor securely. Without sufficient Factor XIII, the connection between the placenta and uterus is too weak to sustain the pregnancy.
Do I need to change my infusion schedule during pregnancy?
During the third trimester, blood volume increases and the body metabolizes medication faster, which can lower Factor XIII levels. Many women need to increase their infusion frequency to every two weeks to maintain safe levels for the baby.
How does Factor XIII deficiency affect my period?
The condition frequently causes menorrhagia, or heavy and prolonged menstrual bleeding. This can be managed with hormonal birth control, antifibrinolytics like tranexamic acid, or Factor XIII infusions during your cycle.
What are the risks during delivery?
The highest risk during childbirth is postpartum hemorrhage, or severe bleeding after delivery. Doctors aim to keep Factor XIII levels above 30-50% during labor to ensure blood clots form properly and prevent delayed bleeding.

Questions for Your Doctor

  • • What is the target Factor XIII level we need to maintain to prevent miscarriage during my first trimester?
  • • Should we move my infusions to every 2 weeks as I enter the third trimester?
  • • Does the hospital have a plan to handle postpartum hemorrhage if my levels drop quickly after birth?
  • • How will we adjust my dose as my weight and blood volume increase during the pregnancy?
  • • How soon after delivery should we test my baby's Factor XIII levels?

Questions for You

  • • How many days does my period typically last, and do I have to change my pad or tampon every hour?
  • • Have I shared my full history of any prior miscarriages or heavy bleeding with my hematologist?
  • • Am I tracking my infusions and any "spotting" carefully during this pregnancy?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Gynecological and obstetric outcome in the French cohort of women with factor XIII deficiency.

    Rugeri L, Martinaud C, Beurrier P, et al.

    Thrombosis research 2020; (191()):22-25 doi:10.1016/j.thromres.2020.04.010.

    PMID: 32360976
  2. 2

    Recombinant factor XIII A-subunit in a patient with factor XIII deficiency and recurrent pregnancy loss.

    Al-Khabori M, Pathare A, Menegatti M, Peyvandi F

    Journal of thrombosis and haemostasis : JTH 2018; (16(6)):1052-1054 doi:10.1111/jth.14126.

    PMID: 29665207
  3. 3

    Mild factor XIII deficiency and concurrent hypofibrinogenemia: effect of pregnancy.

    Kaveney AD, Philipp CS

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2016; (27(4)):457-60 doi:10.1097/MBC.0000000000000448.

    PMID: 26575494
  4. 4

    Clotting Factor Deficiencies as an Underlying Cause of Abnormal Uterine Bleeding in Women of Reproductive Age: A Literature Review.

    Livanou ME, Matsas A, Valsami S, et al.

    Life (Basel, Switzerland) 2023; (13(6)) doi:10.3390/life13061321.

    PMID: 37374104
  5. 5

    Postpartum Hemorrhage in Heterozygote Factor XIII Deficient Women Compared With Healthy Women. A Cross-Sectional Experience From Iran.

    Naderi M, Mirzaei I, Yaghoubi S, et al.

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2021; (27()):10760296211051714 doi:10.1177/10760296211051714.

    PMID: 34697946
  6. 6

    Anovulatory bleeding and the spectrum of bleeding disorders: Understanding heavy menstrual bleeding in adolescents.

    Özer E, Akman AÖ, Kurtipek FB, et al.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2025; doi:10.1002/ijgo.70579.

    PMID: 41074491
  7. 7

    Neoplasm-induced bleeding in inherited, heterozygous FXIII-A deficiency.

    Ivaškevičius V, Goldmann G, Biswas A, et al.

    Hamostaseologie 2015; (35 Suppl 1()):S32-5.

    PMID: 26540128
  8. 8

    Factor XIII deficiency in south of Tunisia.

    Maaloul I, Medhaffer M, Louhichi N, et al.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2017; (28(6)):485-489 doi:10.1097/MBC.0000000000000649.

    PMID: 28704210
  9. 9

    Prenatal diagnosis of factor 13 deficiency and its recurrence.

    Dasari P, Mangolngnbi Chanu S, Gadipudi LP

    BMJ case reports 2020; (13(12)) doi:10.1136/bcr-2020-236365.

    PMID: 33370964
  10. 10

    Advances of Coagulation Factor XIII.

    Shi DY, Wang SJ

    Chinese medical journal 2017; (130(2)):219-223 doi:10.4103/0366-6999.198007.

    PMID: 28091415
  11. 11

    Congenital Factor XIII Deficiency With the Presence of Inhibitor: A Case Study.

    Karaman S, Akkaya E, Genc S, et al.

    Journal of pediatric hematology/oncology 2021; (43(1)):e99-e102 doi:10.1097/MPH.0000000000001671.

    PMID: 31764516
  12. 12

    Treatment with Recombinant Factor XIII (Tretten) in a Pregnant Woman with Factor XIII Deficiency.

    Abdel-Samad N

    The American journal of case reports 2017; (18()):436-439 doi:10.12659/ajcr.901502.

    PMID: 28432284
  13. 13

    Acquired factor XIII deficiency is associated with mortality and is not linked to hypocalcemia.

    Duque P, Esteban ML, Piñeiro P, et al.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2026; (37(1)):28-37 doi:10.1097/MBC.0000000000001400.

    PMID: 41311329
  14. 14

    Successful perinatal management of a woman with congenital factor XIII deficiency using recombinant factor XIII: A case report and literature review.

    Ito Y, Tsuji S, Kasahara M, et al.

    The journal of obstetrics and gynaecology research 2024; (50(2)):262-265 doi:10.1111/jog.15819.

    PMID: 37875278
  15. 15

    Factor XIII deficiency in the Saudi population, an underestimated bleeding risk. Review article and an illustrative case report with dental complications.

    Aljabry M

    The Saudi dental journal 2023; (35(4)):305-309 doi:10.1016/j.sdentj.2023.03.015.

    PMID: 37251713
  16. 16

    Medical and Surgical Management of Postpartum Hemorrhage in a Woman with Factor XIII Deficiency.

    Cheng M, Nassim J, Angha A, et al.

    Case reports in obstetrics and gynecology 2016; (2016()):7963874 doi:10.1155/2016/7963874.

    PMID: 27635271

This guide explains pregnancy and reproductive health management for Factor XIII deficiency for educational purposes. Always consult your hematologist and obstetrician for a personalized care plan.

Stay up to date

Get notified when new research about Factor XIII Deficiency is published.

No spam. Unsubscribe anytime.